FINWIRES · TerminalLIVE
FINWIRES

RBC Trims Price Target on Regeneron Pharmaceuticals to $762 From $779, Keeps Sector Perform Rating

By

Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $880.77 according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $695.73, Change: $+9.37, Percent Change: +1.37%

Related Articles